Results 201 to 210 of about 314,927 (315)
Pleural Effusion in an HIV-Positive Patient: A Case Report and Review of Diagnostic Challenges. [PDF]
Tabarsi P, Hemmatian M, Moradi M.
europepmc +1 more source
Cryptococcid Sweet Syndrome in the Setting of Hydralazine‐Induced ANCA Vasculitis: A Case Report
ABSTRACT Acute febrile neutrophilic dermatosis, also known as Sweet syndrome, is an inflammatory skin condition characterized by the rapid onset of painful, erythematous plaques or nodules with neutrophilic infiltrate on histology. Rarely, acellular bodies surrounded by vacuolated spaces have been noted within the neutrophilic infiltrate, mimicking ...
Jenna Vroman +4 more
wiley +1 more source
Diagnostic value of pleural fluid neuron-specific enolase for malignant pleural effusion. [PDF]
Lin X +13 more
europepmc +1 more source
Abstract This prospective single‐center study aimed to investigate whether preserving cell‐free ribonucleic acid (cfRNA) in specimens' supernatants (SS) obtained from percutaneous core‐needle biopsy (CNB) of non‐small cell lung cancer (NSCLC) can improve the performance of genomic testing.
Sheng Xu +6 more
wiley +1 more source
Metagenomic next-generation sequencing for the diagnosis and evaluation of pediatric pleural effusion: a case series. [PDF]
Xu Z, Gao L, Chen Z, Tang L, Wang Y.
europepmc +1 more source
Safety of Immune Checkpoint Inhibitors in Cancer Patients With Preexisting Autoimmune Vasculitis
Objective Immune checkpoint inhibitors (ICIs) are effective cancer therapies but often cause serious immune‐related adverse events (irAEs). Patients with preexisting autoimmune diseases, including vasculitis, are excluded from trials. We aimed to evaluate the frequency, severity, and outcomes of vasculitis flares and irAEs in this population.
Juan Sevillano +4 more
wiley +1 more source
Increased work of breathing and its relationship to dyspnea in malignant pleural effusion. [PDF]
Gólczewski T +4 more
europepmc +1 more source
PARPi Combining Nanoparticle LIN28B siRNA for the Management of Malignant Ascites
This study demonstrates that co‐inhibition of LIN28B and PARP using siLin28b/DSSP@lip‐PEG‐FA nanoparticles in combination with the PARP inhibitor BMN673 effectively suppresses the accumulation of malignant ascites associated with advanced cancers.
Yan Fang +13 more
wiley +1 more source

